- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 681207, 6 pages
Study Bioprospecting of Medicinal Plant Extracts of the Semiarid Northeast: Contribution to the Control of Oral Microorganisms
1Laboratório de Desenvolvimento e Ensaio de Medicamentos, Universidade Estadual da Paraíba, 58.429-500 Campina Grande, PB, Brazil
2Programa de Pós-graduação em Odontologia, Universidade Estadual da Paraíba, 58.429-500 Campina Grande, PB, Brazil
Received 2 February 2012; Revised 10 April 2012; Accepted 12 April 2012
Academic Editor: Vincenzo De Feo
Copyright © 2012 Maria Suênia P. Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Dental pathologies can be caused by plaque-forming bacteria and yeast, which reside in the oral cavity. The bacteria growing in dental plaque, a naturally occurring biofilm, display increased resistance to antimicrobial agents. The objective was the evaluation of a preclinical assay of medicinal plants of the semiarid region from the northeast against oral pathogenic microorganism, aiming at bioprospecting a new product. The selection of plant material for this study was based on the ethnobotanical data on the traditional use of plants from the semiarid region. The thirty extracts were subjected to the determination of antibiofilm activity against gram-positive, gram-negative bacteria and yeast. The hydroalcoholic extract which showed positive antibiofilm activity against most of the microorganisms tested in agar diffusion assay was further tested for the determination of minimum inhibitory concentration (MIC) and Bioassay with Artemia salina. Plant samples tested in this study exhibited good antibiofilm activity for the treatment of oral problems. The Schinopsis brasiliensis showed greater activity for Pseudomonas aeruginosa and Staphylococcus aureus, but toxicity against Artemia salina.
Dental caries, periodontal disease, and candidiasis are important dental pathologies affecting humankind. These conditions are caused by plaque-forming bacteria and yeast, which reside in the oral cavity. Periodontal diseases have mainly been associated with Actinomyces, Actinobacillus, Streptococcus, and Candida species . It is generally recognized that the bacterial growth in biofilms imparts a substantial decrease in susceptibility to antimicrobial agents compared with cultures grown in suspension. It is therefore not surprising that bacteria growing in dental plaque, a naturally occurring biofilm, display increased resistance to antimicrobial agents .
The resistance development by pathogens to the existing pharmaceutical has led to the intensification of the search for novel drugs, against fungal, parasitic, bacterial, and viral infections. Plant-derived antimicrobials have a long history of providing the much needed novel therapeutics. A number of traditionally used medicinal plants have to date been screened for various biological activities in both in vivo and in vitro models. The chemical investigation from medicinal plants purported to have medicinal properties has yielded numerous purified compounds which have proven to be indispensable in the practice of modern medicine .
Brazil has a great potential for biodiversity and wealth of traditional knowledge accumulated by local people who have direct access to nature and the products of biodiversity. In this sense, the Caatinga, main semiarid’s biome, represents the fourth largest area covered by a single vegetation form in Brazil, accounting for about 60% of the northeast territory. There has been increasing interest in acquiring knowledge regarding the medicinal plants within the Caatinga area, and some publications describe the rich flora of this region as having many medicinal purposes .
This work aims at the evaluation of a preclinical assay of medicinal plants from the folk medicine of the semiarid region of the northeast against oral pathogenic microorganisms, in order to bioprospect a new product.
2. Materials and Methods
2.1. Plant Materials
The medicinal plants were collected from the semiarid region in the State of Paraíba. Voucher specimen were prepared and identified at the Professor Jayme Coelho de Morais Herbarium (PRU), Federal University of Paraiba and at the Dárdamo de Andrade Lima herbarium Agronomic Institute of Pernambuco (Table 1).
2.2. Extracts Preparation
The plant material was air dried at 40°C and ground to a fine powder. The powdered material (200 g) was extracted with 1000 mL ethanol/distilled water with 10, 20, 30, 50, and 70% (v/v) for 5 days with occasional stirring, accordingly named as HEx1, HEx2, HEx3, HEx4, and HEx5, respectively, and stored at room temperature in amber flasks.
2.3. Antibiofilm Activity
The microorganisms used in this study included Pseudomonas aeruginosa (ATCC 27853), Streptococcus mutans (ATCC 25175), Streptococcus salivarius (ATCC 7073), Streptococcus oralis (ATCC 10557), Lactobacillus casei (ATCC 7469), Enterococcus faecalis (ATCC 29212), Staphylococcus aureus (ATCC 25923), Candida albicans (ATCC 18804), Candida tropicalis (ATCC 13803), Candida krusei (ATCC 34135). Bacteria were grown in the Mueller Hinton agar medium with 5% blood agar under anaerobic conditions in anaerobic jar, at 37°C for 48 h. Sabouraud Dextrose Agar medium was used for culturing Candidas at 25°C for 24 h under aerobic conditions.
2.3.1. Cylinder-Plate Assay
The microorganisms were individually inoculated into tubes containing 5 mL sterile 0.9% saline solution. The suspension was adjusted spectrophotometrically at 625 nm which is equivalent to 106 CFU/mL. The agar was composed of 2 separate layers, and only the upper layer was inoculated. The Mueller Hinton agar (20 mL) was poured into microbiological Petri dish for the base layer. After solidification, the other layer containing 5 mL inoculated medium, with the different microorganisms, was distributed to the surface of each base layer. For the 5 × 1 design, six stainless-steel cylinders of uniform size (8 mm × 6 mm × 10 mm) were placed on the surface of inoculated agar, and an exactly measured volume (100 μL) of the corresponding extract was deposited into five cylinders, while the other one was filled with either the standard solution. In the bioassay, ten plates were prepared. All plates were left for 2 hour at room temperature and then incubated at (for bacteria) for 24 h and (for yeast) for 24 h. The diameter (in mm) of growth inhibition zones was carefully measured using a caliper with at least 0.1 mm accuracy.
2.3.2. Minimal Inhibitory Concentration (MIC) Determination
The assay was performed by the broth microdilution method. It was performed in 96 well microplates according to the Clinical and Laboratory Standards Institute  procedures. The inoculums were standardized in tubes containing 5 mL sterile 0.9% saline solution. The suspension was adjusted spectrophotometrically at 625 nm which is equivalent to 106 CFU/mL. One hundred microlitres of each hydroalcoholic extract were serially diluted threefold with sterile Mueller Hinton broth or with sterile Sabouraud Dextrose broth in a 96-well microlitre plate for each microorganisms strains studied. A similar threefold serial dilution of chlorhexidine was used as a positive control against each bacterium and nystatin against each Candida. One hundred microlitres of each microorganism culture were added to each well. Ethanol/water was included as negative controls. The plate incubated at (for bacteria) for 24 h and (for yeast) for 24 h. Bacterial growth was indicated by adding 20 μL of aqueous solution of resazurin (Sigma-Aldrich) to 0.01% with further incubation at for 2 h. Viable bacteria reduced the yellow dye to a pink color. The MIC was defined as the lowest concentration that inhibited the colour change of resazurin.
2.4. Bioassay with Artemia salina
This bioassay was performed with extracts that showed antibiofilm activity to evaluate the EtOH extract toxicity; it used the brine shrimp (Artemia salina) lethality test. The 50 g of eggs of A. salina were incubated in sea water (pH 8 ± 0,5 and 28°C) at artificial light during 24–36 hours for cysts occlusion and larvae obtaining. After hatching, they were collected and put into tubes containing different EtOH extract concentrations (2000, 1500, 1000, 500, and 250 μg/mL), and the blank control was always conduced. The set was incubated at artificial light for 24 h, and then the survivor larvae were counted to determine the LC50 using the Probit method. The bioassay was repeated three times. As the measure of extract toxicity, the LC50 value lower than 1000 μg/mL is considered bioactive .
2.5. Statistical Analysis
The results were expressed as mean. Differences among means were statistically compared using the Student’s -test for antibiofilm assay. The values were considered significantly different when . The software used was the Origin software. The LC50 for Bioassay with A. salina was determined according to the Probit statistical method using the software STATPLUS 2005.
3. Results and Discussion
3.1. Antibiofilm Activity
The selection of plant material for this study was based on the ethnobotanical data on the traditional use of plants from the semiarid region. The thirty extracts were subjected to the determination of antibiofilm activity against gram-positive, gram-negative bacteria and yeast (Table 2). The extracts of H. mutabilis and A. coriacea presented no inhibitory activity against the microorganisms tested, but Toledo et al.  showed that the extract obtained from A. coriacea showed the best activity against Candida albicans and C. parapsilosis. All extracts exhibited antibacterial activity against S. oralis. The growth of S. mutans, S. salivarius, L. casei, C. albican, C. tropicalis, and C. krusei was not inhibited by any concentration of extracts tested.
The A. hispidum extract presented activity only against S. oralis. The study conducted by Ederwor and Olajire  confirms the antimicrobial activity of the extracts of P. aeruginosa and S. aureus.
The X. americana bark extract showed activity against E. faecalis, S. aureus, and S. oralis. The zones of inhibition observed at E. faecalis were statistically different compared with those of chlorhexidine (positive control). And for another bacterium, the chlorhexidine presented bigger inhibition halo than that promoted by the E. faecalis and S. aureus. Costa et al.  demonstrated the antimicrobial activity of the X. americana bark extracts at E. faecalis and showed that they may represent alternative substances in endodontic treatment. And in another study Falcão and Menezes  observed that C. albicans was the least susceptible among the tested yeast.
The best results were obtained with S. brasiliensis extract against S. aureus. This extract presents higher efficacy in the HEx5 for P. aeruginosa, Hex1–Hex4 for S. aureus, and Hex1–Hex3 for S. oralis compared with chlorhexidine. This result was consistent with that discussed by Goleniowski et al.  and de Barros et al. . This confirmed that antibiofilm activity can be related to the higher proportion of tannins and flavonoids in the plant like the observed by Siqueira et al. .
The hydroalcoholic extract which showed positive antibiofilm activity against most of the microorganisms tested in agar diffusion assay was further tested for the determination of minimum inhibitory concentration (MIC) and Bioassay with Artemia salina.
3.2. Minimal Inhibitory Concentration (MIC) Determination
Studies showed that the MIC values indicate that S. brasiliensis extract was more efficient, corroborating the results of the previous experiment. The important activity on S. aureus confirms the best activity obtained in cylinder-plate assay, which revealed this strain as one of the most susceptible with MIC ranging from 0.250 to 0.063 μL/μL. The S. oralis strain was the least sensitive (MIC = 1.000 μL/μL). The P. aeruginosa HEx1 was the most sensitive (MIC = 0.004 μL/μL). Similar result was found by Goleniowski et al.  and de Barros et al. .
The X. americana extract presented activity against S. aureus (MIC = 0.250–0.063 μL/μL), E. faecalis (MIC = 1.000 μL/μL), and S. oralis (MIC = 1.000 μL/μL). Omer and Elnima  reported activity of the methanolic and aqueous extract against S. aureus. Koné et al.  demonstrated that the ethanolic root extract exhibited some activity against S. aureus and E. faecalis.
3.3. Bioassay with Artemia salina
Determination of the toxicity to Artemia salina has been used efficiently to analyze the biological potential of plant extracts. Several natural compounds, particularly substances with antitumoral, antimicrobial, insecticidal, and antitrypanosomal activity, have been tested through these bioassays showing significant correlation .
The results showed that the extract of A. hispidum presented LC50 = 4.101 μg/mL, S. brasiliensis LC50 = 428 μg/mL, and X. americana LC50 = 4.262. Meyer et al.  described a lethal concentration (LC50) based on the toxicity of substances to the larvae of A. salina. According to the scale, LC50 values < 500 μg·mL−1 indicate toxicity, LC50 between 500 and 1000 μg·mL−1 denote moderate toxicity, while LC50 > 1000 μg·mL−1 suggest lack of toxicity.
In this work S. brasiliensis showed data that indicate toxicity. The study conducted by de Barros et al.  confirms the possible plant toxicity. It was related that this can be explained by the high concentration of polyphenols (tannin, flavonoids, and other phenolics compounds) present in this plant and which are well known for their toxicity against A. salina.
Plant samples tested in this study exhibited good antibiofilm activity for the treatment of oral problems. The S. brasiliensis showed higher activity for P. aeruginosa and S. aureus, but toxicity against Artemia salina. The result suggests that studies to isolate and characterize the antibiofilm compounds of S. brasiliensis Engl, whereas their high antibacterial activity could be the base of development of new phytotherapic product with broad spectra. Studies in vivo of toxicity are essential.
This reinforces the concept that the ethnobotanical investigation of used plants is necessary since it will reveal a great number of positive responses in in vitro tests.
The authors are grateful to Fundação de Apoio à Pesquisa do Estado da Paraíba (FAPESQ) for financial aid and to Fundação Oswaldo Cruz that donated the ATTC strains.
- G. More, T. E. Tshikalange, N. Lall, F. Botha, and J. J. M. Meyer, “Antimicrobial activity of medicinal plants against oral microorganisms,” Journal of Ethnopharmacology, vol. 119, no. 3, pp. 473–477, 2008.
- N. S. Soukos and J. M. Goodson, “Photodynamic therapy in the control of oral biofilms,” Periodontology 2000, vol. 55, no. 1, pp. 143–166, 2011.
- B. Ncube, J. F. Finnie, and J. van Staden, “In vitro antimicrobial synergism within plant extract combinations from three South African medicinal bulbs,” Journal of Ethnopharmacology, vol. 139, no. 1, pp. 81–89, 2012.
- S. L. Cartaxo, M. M. de Almeida Souza, and U. P. de Albuquerque, “Medicinal plants with bioprospecting potential used in semi-arid northeastern Brazil,” Journal of Ethnopharmacology, vol. 131, no. 2, pp. 326–342, 2010.
- M. F. Agra, G. S. Baracho, K. Nurit, I. J. L. D. Basílio, and V. P. M. Coelho, “Medicinal and poisonous diversity of the flora of “Cariri Paraibano”, Brazil,” Journal of Ethnopharmacology, vol. 111, no. 2, pp. 383–395, 2007.
- M. D. F. Agra, K. N. Silva, I. J. L. D. Basílio, P. F. De Freitas, and J. M. Barbosa-Filho, “Survey of medicinal plants used in the region Northeast of Brazil,” Brazilian Journal of Pharmacognosy, vol. 18, no. 3, pp. 472–508, 2008.
- G. F. Scarpa, “Medicinal plants used by the Criollos of Northwestern Argentine Chaco,” Journal of Ethnopharmacology, vol. 91, no. 1, pp. 115–135, 2004.
- A. Asase, A. A. Oteng-Yeboah, G. T. Odamtten, and M. S. J. Simmonds, “Ethnobotanical study of some Ghanaian anti-malarial plants,” Journal of Ethnopharmacology, vol. 99, no. 2, pp. 273–279, 2005.
- B. G. Brasileiro, V. R. Pizziolo, D. S. Raslan, C. M. Jamal, and D. Silveira, “Antimicrobial and cytotoxic activities screening of some Brazilian medicinal plants used in Governador Valadares district,” Brazilian Journal of Pharmaceutical Sciences, vol. 42, no. 2, pp. 195–202, 2006.
- U. P. de Albuquerque, P. M. de Medeiros, A. L. S. de Almeida et al., “Medicinal plants of the caatinga (semi-arid) vegetation of NE Brazil: a quantitative approach,” Journal of Ethnopharmacology, vol. 114, no. 3, pp. 325–354, 2007.
- P. Nadembega, J. I. Boussim, J. B. Nikiema, F. Poli, and F. Antognoni, “Medicinal plants in Baskoure, Kourittenga Province, Burkina Faso: an ethnobotanical study,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 378–395, 2011.
- O. V. Sousa, G. Del-Vechio-Vieira, and M. A. C. Kaplan, “Analgesic and anti-inflammatory properties of Annona coriacea Mart. (Annonaceae) leaves methanol extract,” Latin American Journal of Pharmacy, vol. 26, no. 6, pp. 872–877, 2007.
- C. A. T. Siqueira, J. Oliani, A. Sartoratto et al., “Chemical constituents of the volatile oil from leaves of Annona coriacea and in vitro antiprotozoal activity,” Brazilian Journal of Pharmacognosy, vol. 21, no. 1, pp. 33–40, 2011.
- M. E. Goleniowski, G. A. Bongiovanni, L. Palacio, C. O. Nuñez, and J. J. Cantero, “Medicinal plants from the “Sierra de Comechingones”, Argentina,” Journal of Ethnopharmacology, vol. 107, no. 3, pp. 324–341, 2006.
- F. M. C. de Barros, K. N. Pereira, G. D. Zanetti, and B. M. Heinzmann, “Medicinal plants used by people from São Luiz Gonzaga, RS, Brazil,” Latin American Journal of Pharmacy, vol. 26, no. 5, pp. 652–662, 2007.
- D. Q. Falcão and F. S. Menezes, “Revisão etnofarmacológica, farmacológica e química do gênero Hyptis,” Revista Brasileira Farmácia, vol. 84, no. 3, pp. 69–74, 2003.
- M. Coelho-Ferreira, “Medicinal knowledge and plant utilization in an Amazonian coastal community of Marudá, Pará State (Brazil),” Journal of Ethnopharmacology, vol. 126, no. 1, pp. 159–175, 2009.
- J. Sanz-Biset, J. Campos-de-la-Cruz, M. A. Epiquién-Rivera, and S. Cañigueral, “A first survey on the medicinal plants of the Chazuta valley (Peruvian Amazon),” Journal of Ethnopharmacology, vol. 122, no. 2, pp. 333–362, 2009.
- M. de Fátima Agra, P. F. de Freitas, and J. M. Barbosa-Filho, “Synopsis of the plants known as medicinal and poisonous in Northeast of Brazil,” Brazilian Journal of Pharmacognosy, vol. 17, no. 1, pp. 114–140, 2007.
- U. P. de Albuquerque, “Re-examining hypotheses concerning the use and knowledge of medicinal plants: a study in the Caatinga vegetation of NE Brazil,” Journal of Ethnobiology and Ethnomedicine, vol. 2, article 30, pp. 1–10, 2006.
- D. S. Ogunley and S. F. Ibitoye, “Studies of antimicrobial activity and chemical constituents of Ximenia americana,” Tropical Journal of Pharmaceutical Research, vol. 2, no. 2, pp. 239–241, 2003.
- E. A. P. Franco and R. F. M. Barros, “Uso e diversidade de plantas medicinais no Quilombo Olho D’água dos Pires, Esperantina, Piauí,” Revista Brasileira de Plantas Medicinais, vol. 8, no. 3, pp. 78–88, 2006.
- H. Tapsoba and J. P. Deschamps, “Use of medicinal plants for the treatment of oral diseases in Burkina Faso,” Journal of Ethnopharmacology, vol. 104, no. 1-2, pp. 68–78, 2006.
- T. E. Grønhaug, S. Glæserud, M. Skogsrud et al., “Ethnopharmacological survey of six medicinal plants from Mali, West-Africa,” Journal of Ethnobiology and Ethnomedicine, vol. 4, no. 26, pp. 1–11, 2008.
- T. Jiofack, C. Fokunang, N. Guedje et al., “Ethnobotanical uses of medicinal plants of two ethnoecological regions of Cameroon,” International Journal of Medicine and Medical Sciences, vol. 2, no. 3, pp. 60–79, 2010.
- F. C. S. Oliveira, R. F. M. Barros, and J. M. Moita Neto, “Medicinal plants used in rural communities from Oeiras Municipality, in the semi-arid region of Piauí State (PI), Brazil,” Revista Brasileira de Plantas Medicinais, vol. 12, no. 3, pp. 282–301, 2010.
- CLSI, “Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically,” NCCLS Document M7A6, 2003.
- B. N. Meyer, N. R. Ferrigni, and J. E. Putnam, “Brine shrimp: a convenient general bioassay for active plant constituents,” Planta Medica, vol. 45, no. 1, pp. 31–34, 1982.
- C. E. M. de Toledo, E. A. Britta, L. F. Ceole et al., “Antimicrobial and cytotoxic activities of medicinal plants of the Brazilian cerrado, using Brazilian cachaa as extractor liquid,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 420–425, 2011.
- T. I. Ederwor and A. A. Olajire, “Two Flavones from Acanthospermum hispidum DC and their antibacterial activity,” International Journal of Organic Chemistry, vol. 1, no. 3, pp. 132–141, 2011.
- E. M. M. de Brito Costa, A. S. Barbosa, T. A. de Arruda et al., “In vitro antimicrobial activity of plant extracts against Enteroccus faecalis,” Jornal Brasileiro de Patologia e Medicina Laboratorial, vol. 46, no. 3, pp. 175–180, 2010.
- D. Q. Falcão and F. S. Menezes, “The Hyptis genus: an ethnopharmacological and chemical review,” Revista Brasileira de Farmácia, vol. 84, no. 3, pp. 69–74, 2003.
- C. F. de Q. Siqueira, D. L. V. Cabral, T. J. da S. Peixoto Sobrinho et al., “Levels of tannins and flavonoids in medicinal plants: evaluating bioprospecting strategies,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 434782, 7 pages, 2012.
- M. E. F. A. Omer and E. I. Elnima, “Antimicrobial activity of Ximenia americana,” Fitoterapia, vol. 74, no. 1-2, pp. 122–126, 2003.
- W. M. Koné, K. K. Atindehou, C. Terreaux, K. Hostettmann, D. Traoré, and M. Dosso, “Traditional medicine in North Côte-d'Ivoire: screening of 50 medicinal plants for antibacterial activity,” Journal of Ethnopharmacology, vol. 93, no. 1, pp. 43–49, 2004.
- H. H. Moresco, G. S. Queiroz, M. G. Pizzolatti, and I. M. C. Brighente, “Chemical constituents and evaluation of the toxic and antioxidant activities of Averrhoa carambola leaves,” Brazilian Journal of Pharmacognosy, vol. 22, no. 2, 2012.